Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) closed the day trading at $5.44 down -7.95% from the previous closing price of $5.91. In other words, the price has decreased by -$7.95 from its previous closing price. On the day, 0.64 million shares were traded. CRVS stock price reached its highest trading level at $6.05 during the session, while it also had its lowest trading level at $5.31.
Ratios:
For a better understanding of CRVS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on August 18, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
On May 27, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $10.Cantor Fitzgerald initiated its Overweight rating on May 27, 2021, with a $10 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 06 ’24 when Jones William Benton bought 20,000 shares for $1.73 per share. The transaction valued at 34,624 led to the insider holds 153,773 shares of the business.
MILLER RICHARD A MD bought 577,634 shares of CRVS for $1,000,000 on May 06 ’24. The President and CEO now owns 577,634 shares after completing the transaction at $1.73 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRVS now has a Market Capitalization of 340279072 and an Enterprise Value of 293732960.
Stock Price History:
Over the past 52 weeks, CRVS has reached a high of $6.15, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is 48.05%, while the 200-Day Moving Average is calculated to be 130.03%.
Shares Statistics:
Over the past 3-months, CRVS traded about 357.78K shares per day on average, while over the past 10 days, CRVS traded about 729350 shares per day. A total of 62.55M shares are outstanding, with a floating share count of 50.12M. Insiders hold about 19.87% of the company’s shares, while institutions hold 27.89% stake in the company. Shares short for CRVS as of 1724976000 were 1434294 with a Short Ratio of 4.01, compared to 1722384000 on 1147839. Therefore, it implies a Short% of Shares Outstanding of 1434294 and a Short% of Float of 2.8399997999999997.
